MustGrow BiologicsMGROF -0.49%24 Return-on-Tangible-Asset is -169.16% as of Mar. 2026. GuruFocus rates MGROF with a GF Score™ of 24/100. The stock has 3 warning signs investors should review. Among 258 Agriculture companies, MustGrow Biologics ranks worse than 99.61% on this metric.
Return-on-Tangible-Asset is calculated as Net Income divided by its average total tangible assets. Total tangible assets equals to Total Assets minus Intangible Assets. MustGrow Biologics's annualizedNet Income for the quarter that ended in Mar. 2026 was $-3.86 Mil. MustGrow Biologics's average total tangible assets for the quarter that ended in Mar. 2026 was $2.28 Mil. Therefore, MustGrow Biologics's annualized Return-on-Tangible-Asset for the quarter that ended in Mar. 2026 was -169.16%.
The historical rank and industry rank for MustGrow Biologics's Return-on-Tangible-Asset or its related term are showing as below:
MGROF'
s Return-on-Tangible-Asset Range Over the Past 10 Years
Min: -2329.41 Med: -85.85 Max: -9.62
Current: -146.3
During the past 10 years, MustGrow Biologics's highest Return-on-Tangible-Asset was -9.62%. The lowest was -2329.41%. And the median was -85.85%.
MGROF's Return-on-Tangible-Asset is ranked worse than 99.61% of 258
companies
in the Agriculture industry
Industry Median: 3.495
vs MGROF: -146.30
Return-on-Tangible-Asset measures the rate of return on the average total tangible assets (total assets minus intangible assets). Tangible means physical in nature. Intangible Assets are assets that are not physical in nature, and typically "derive their value from legal or intellectual rights." Return-on-Tangible-Asset measures a firm's efficiency at generating profits from its tangible assets. It shows how well a company uses what it has to generate earnings. Return-on-Tangible-Assets can vary drastically across industries. Therefore, Return-on-Tangible-Asset should not be used to compare companies in different industries.
Be Aware
Like ROE and ROA, Return-on-Tangible-Asset is calculated with only 12 months data. Fluctuations in the companys earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective. Return-on-Tangible-Asset can be affected by events such as stock buyback or issuance, and by a companys tax rate and its interest payment. Return-on-Tangible-Asset may not reflect the true earning power of the assets. A more accurate measurement is ROC % (ROC).
Many analysts argue the higher return the better. Buffett states that really high Return-on-Tangible-Asset may indicate vulnerability in the durability of the competitive advantage.
MustGrow Biologics Return-on-Tangible-Asset Related Terms
MustGrow Biologics Return-on-Tangible-Asset Historical Data
* Premium members only.
The historical data trend for MustGrow Biologics's Return-on-Tangible-Asset can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
MGROF vs CTVA, CF, MOS: Return-on-Tangible-Asset Comparison
For the Agricultural Inputs subindustry, MustGrow Biologics's Return-on-Tangible-Asset, along with its competitors' market caps and Return-on-Tangible-Asset data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
MustGrow Biologics Return-on-Tangible-Asset vs Agriculture Industry
For the Agriculture industry and Basic Materials sector, MustGrow Biologics's Return-on-Tangible-Asset distribution charts can be found below:
* The bar in red indicates where MustGrow Biologics's Return-on-Tangible-Asset falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Return-on-Tangible-Asset, the net income of the last fiscal year and the average total tangible assets over the fiscal year are used. In calculating the quarterly data,
the Net Income data used here is four times the quarterly (Mar. 2026) net income data.
What does a Return-on-Tangible-Asset of -169.16% mean?
MustGrow Biologics (MGROF) has a Return-on-Tangible-Asset of -169.16% as of Mar. 2026. Return on tangible assets is the ratio of current-period net income to average two-period tangible assets. View historical data on MustGrow Biologics and its competitors. According to the industry distribution chart, MustGrow Biologics ranks #257 out of 258 companies in the Agriculture industry, placing it in the top 99.6%.
Is MustGrow Biologics' Return-on-Tangible-Asset too high?
MustGrow Biologics' current Return-on-Tangible-Asset is -169.16%. Based on the distribution chart, MustGrow Biologics ranks #257 out of 258 companies in the Agriculture industry, which is in the bottom quartile relative to peers. Overall, MustGrow Biologics has a GF Score™ of 24/100, reflecting its overall financial health beyond just this single metric.
How does MustGrow Biologics' Return-on-Tangible-Asset compare to CTVA and CF?
According to the Agriculture industry distribution chart, MustGrow Biologics ranks #257 out of 258 companies for Return-on-Tangible-Asset. This places MustGrow Biologics in the lower half of its industry. The industry median Return-on-Tangible-Asset is 3.50. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Return-on-Tangible-Asset for an Agriculture company?
The median Return-on-Tangible-Asset among Agriculture companies is 3.50, based on 258 companies in the industry. Companies in the top quartile (top 25%) have a Return-on-Tangible-Asset significantly above this median, while those in the bottom quartile fall well below. However, Return-on-Tangible-Asset should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Return-on-Tangible-Asset mean?
A high Return-on-Tangible-Asset can signal that a stock is expensive relative to its fundamentals. Return on tangible assets is the ratio of current-period net income to average two-period tangible assets. View historical data on MustGrow Biologics and its competitors. For the Agriculture industry, the median Return-on-Tangible-Asset is 3.50 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. MustGrow Biologics's current Return-on-Tangible-Asset is -169.16%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is MustGrow Biologics stock overvalued right now?
MustGrow Biologics (MGROF) has a current Return-on-Tangible-Asset of -169.16%. The current Return-on-Tangible-Asset is -169.16%. MustGrow Biologics' overall GF Score™ is 24/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Return-on-Tangible-Asset calculated?
Return-on-Tangible-Asset is calculated from a company's financial statements. For MustGrow Biologics (MGROF), the current Return-on-Tangible-Asset is -169.16% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
MustGrow Biologics Corp is a fully integrated provider of biological and regenerative agriculture solutions designed to support sustainable farming. The Company's proprietary and third-party product lines offer eco-friendly alternatives to restricted or banned synthetic chemicals and fertilizers. It offers a portfolio of third-party crop nutrition solutions, including micronutrients, nitrogen stabilizers, biostimulants, and foliar products. These products are synergistically distributed alongside MustGrow's wholly owned proprietary products and technologies that are derived from mustard and developed into organic biocontrol and biofertility products to help replace banned or restricted synthetic chemicals and fertilizers.
24GF Score
Get the complete analysis for MGROF
Return-on-Tangible-Asset is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MGROF has been successfully added to your 
